November 2023 PMID 37774329

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

Jaydira Del Rivero, Kimberly Perez, Erin B Kennedy, Erik S Mittra, Namrata Vijayvergia, Junaid Arshad, Sandip Basu, Aman Chauhan, Arvind N Dasari, Andrew M Bellizzi, Alexandra Gangi, Erin Grady, James R Howe, Jana Ivanidze, Mark Lewis

Mentions

120
Peak: 48 in Sep 2023
across 2 sources since Sep 2023

Extended reach

659,201
potential audience

Total likes

314

Video views

198

Mentions per month

Sep 2023 – May 2025

Where it's discussed

  • X / Twitter118 posts
  • YouTube2 videos

AI synopsis

What people are saying

Numerous discussions highlight the importance of the ASCO guidelines, with comments such as 'honored to have contributed' and 'truly grateful to be part of the first ASCO guideline.' Contributors often use encouraging language to convey their enthusiasm, stating this work will greatly aid in the management of NETs. The tone across the discussions is celebratory and cooperative, indicating a shared belief in the potential impact of the guidelines on patient care.

AgreementStrong agreement

The overwhelming majority of discussions express strong support for the guidelines.

InterestHigh interest

The posts showcase a high level of curiosity and importance regarding the guidelines.

EngagementHigh engagement

Many contributors reference specific aspects of the recommendations and express gratitude for the collaborative effort.

ImpactHigh impact

Users perceive the guidelines as having a significant effect on treatment practices for neuroendocrine tumors.

Abstract in brief

  • The purpose of the study was to create guidelines for treating metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) from grade 1 to grade 3.
  • The review identified eight clinical trials that helped inform these treatment recommendations, backed by an expert panel from ASCO.
  • Key recommendations include using somatostatin analogs (SSAs) as the first-line therapy for many patients, considering observation for low-risk cases, and prescribing peptide receptor radionuclide therapy (PRRT) or everolimus as second-line options based on tumor characteristics.

Top posts

Most liked on X and Bluesky
Yakup Ergün
@dr_yakupergun · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Sep 29, 2023 · 92 likes · 50 shares · 5,837 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO @ASCOPost for giving us the opportunity to work on this important effort & to provide guidance in the care of patients living with NETs! https://t.co/sW35kXZ0QG

Nov 10, 2023 · 54 likes · 8 shares · 1,299 followers View post →
NET CONNECT
@net_connectinfo · X

Oct 2, 2023 · 27 likes · 8 shares · 1,210 followers View post →
WCM Molecular Imaging and Therapeutics
@MolecularWCM · X

Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs, published in @JCO_ASCO!

Oct 1, 2023 · 23 likes · 7 shares · 482 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 22 likes · 6 shares · 1,299 followers View post →
Junaid Arshad
@drjunaidarsh · X

Check out our latest addition @ASCO Treatment Guidelines for the treatment of Well Diff. GEP NETS. Thank you to my mentors @rachnatshroff @ajscott40 @adasarimd @UAZHemeOnc @UAZCancer Chairs @JaydiDelRivero KimberlyPerez and other wonderful members. https://t.co/TbAZhM8IsF

Oct 1, 2023 · 21 likes · 3 shares · 341 followers View post →

All mentions

Richard Ken Suzuki, PhD
@RichardKenSuzu1 · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 27, 2025 · 7 shares · 240 followers View post →
Cancer at Cedars-Sinai
@CSCancerCenter · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 25, 2025 · 7 shares · 1,688 followers View post →
MOASC
@MOASC_Office · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 24, 2025 · 7 shares · 664 followers View post →
Cristiane D Bergerot
@crisbergerot · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 24, 2025 · 7 shares · 8,162 followers View post →
Diana Rubio
@dra_alerubio · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 24, 2025 · 7 shares · 28 followers View post →
Stefania Colasanti
@Stefani19753108 · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 24, 2025 · 7 shares · 815 followers View post →
OncoAlert
@OncoAlert · X

RT @jgong15: Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in stea…

Mar 24, 2025 · 7 shares · 39,874 followers View post →
Jun Gong
@jgong15 · X

Highlighting seminal work from #KOL speakers at the 6th Annual @CSCancerCenter GI Tumor Conf: @AGangiMD: Tumor growth in steatotic liver & #GEPNET @ASCO guidelines https://t.co/V1HIAIWjXn https://t.co/nRJLsaow8E April 5, 2025. Register at https://t.co/ygFRaIUvTJ @OncoAlert https://t.co/C1sfOBkM2d

Mar 24, 2025 · 10 likes · 7 shares · 1,651 followers View post →
Clinical Trials Office, Huntsman Cancer Institute
@Huntsman_CTO · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Jan 27, 2024 · 8 shares · 113 followers View post →
Pamela Kunz, MD, FASCO
@PamelaKunzMD · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Jan 27, 2024 · 8 shares · 8,366 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Jan 27, 2024 · 8 shares · 1,299 followers View post →
なつぞら
@natsu_oncol · X

ちょうどASCOガイドラインの新しいものが出たばかり。こちらは症候性/高腫瘍量のpanNETにはCAPTEMを弱く推奨 https://t.co/5ZYPc61i1A https://t.co/aLzpKEmPjI

Dec 6, 2023 View post →
Kurt Tiger (pseudonym)
@shaorn43 · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 12, 2023 · 6 shares · 16 followers View post →
NETs México
@NETsMexico · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 11, 2023 · 6 shares · 300 followers View post →
Ghassan Abou-Alfa
@GABOUALFA · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Nov 11, 2023 · 8 shares · 5,385 followers View post →
Eileen M O’Reilly
@EileenMOReilly · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Nov 11, 2023 · 8 shares · 6,329 followers View post →
J Hernando
@JHernando3 · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Nov 10, 2023 · 8 shares · 1,246 followers View post →
Zach Yeung MD
@zpyeung · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 6 shares · 673 followers View post →
Andrew Bellizzi
@IHC_guy · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Nov 10, 2023 · 8 shares · 8,352 followers View post →
Julie Hallet
@HalletJulie · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 6 shares · 6,129 followers View post →
Jana Ivanidze
@jana_ivanidze · X

RT @JaydiDelRivero: Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO…

Nov 10, 2023 · 8 shares · 2,122 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

Truly grateful to be part of the first ASCO guideline for the management of NETs and everyone involved! Thank you @ASCO @ASCOPost for giving us the opportunity to work on this important effort & to provide guidance in the care of patients living with NETs! https://t.co/sW35kXZ0QG

Nov 10, 2023 · 54 likes · 8 shares · 1,299 followers View post →
Heloisa Soares MD
@helops79 · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 6 shares · 2,337 followers View post →
Aman Chauhan
@AmanChauhanMD · X

RT @JaydiDelRivero: Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 6 shares · 2,737 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

Let’s Talk About NETs!!#NETCancerAwarenessDay

Nov 10, 2023 · 22 likes · 6 shares · 1,299 followers View post →
Amol S Bhardwaj
@BhardwajAmolS · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | Journal of Clinical Oncology https://t.co/2QxcHBjqd0

Nov 5, 2023 · 2 likes · 550 followers View post →
Irina
@Irina15952203 · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 5, 2023 · 10 shares · 31 followers View post →
Anna Malovanna
@malyovannaya_a · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 5, 2023 · 10 shares · 96 followers View post →
Anmol Singh, MD
@MDanmolsingh · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 5, 2023 · 10 shares · 713 followers View post →
Ji Hyun Kim
@writ__e · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 348 followers View post →
Чиж
@rough_fiddle · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 9 followers View post →
Burak Alper Zengin
@dralperzeng · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 46 followers View post →
nel cuevas muñoz
@MunozNel · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 147 followers View post →
Stephen Kearney
@SJKBio · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 713 followers View post →
ASCO
@ASCO · X

RT @JCO_ASCO: ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @AS…

Nov 4, 2023 · 10 shares · 149,459 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

ICYMI: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic #NeuroendocrineTumors: @ASCO Guideline

Nov 4, 2023 · 6 likes · 10 shares · 54,551 followers View post →
Goutham Sunny
@medoncodoc · X

RT @drkpavithran: Metastatic well-differentiated Gastroenteropancreatic NET- Systemic therapy ASCO guideline https://t.co/CO7cgyGDGN https:…

Oct 5, 2023 · 1,020 followers View post →
K Pavithran
@drkpavithran · X

Metastatic well-differentiated Gastroenteropancreatic NET- Systemic therapy ASCO guideline https://t.co/CO7cgyGDGN https://t.co/bZqf6wLDDT

Oct 4, 2023 · 9 likes · 1,330 followers View post →
Isaura R. Penin
@irodriguezpenin · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline https://t.co/w4DK5T8R2M

Oct 4, 2023 · 1 like · 624 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

RT @Globeseek: https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero…

Oct 3, 2023 · 5 shares · 1,299 followers View post →
Jaydira Del Rivero, MD
@JaydiDelRivero · X

RT @drjunaidarsh: Check out our latest addition @ASCO Treatment Guidelines for the treatment of Well Diff. GEP NETS. Thank you to my mentor…

Oct 3, 2023 · 3 shares · 1,299 followers View post →
EndocrinoHUVR
@EndocrinoHUVR · X

RT @NeuroendocrinoS: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASC…

Oct 3, 2023 · 1 share · 3,180 followers View post →
Ana Carle
@analeoca66 · X

RT @dralanburguete: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Oct 3, 2023 · 1 share · 1,328 followers View post →
NeuroendocrinoSEEN
@NeuroendocrinoS · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | Journal of Clinical Oncology https://t.co/XEwnS1t5IZ

Oct 3, 2023 · 1 like · 1 share · 2,883 followers View post →
Alan Burguete-Torres M.D.
@dralanburguete · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | Journal of Clinical Oncology https://t.co/5OpJ0hrFDC

Oct 2, 2023 · 19 likes · 1 share · 1,534 followers View post →
Alejandro Roman-Gonzalez
@alejoromanmd · X

Guías nuevas @ASCO sobre GEP-NET metastásico. https://t.co/1ae4MjOrZW

Oct 2, 2023 · 3 likes · 3,812 followers View post →
Neuroendocrine Cancer UK #NotJustNECancer
@ncukcharity · X

RT @net_connectinfo:

Oct 2, 2023 · 8 shares · 5,068 followers View post →
Jose Rodriguez, MD
@JoseA_Rodr · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 2, 2023 · 7 shares · 1,080 followers View post →
SOGAMN gallega de medicina nuclear
@SogamnOficial · X

RT @net_connectinfo:

Oct 2, 2023 · 8 shares · 190 followers View post →
Thor Halfdanarson
@OncoThor · X

RT @net_connectinfo:

Oct 2, 2023 · 8 shares · 5,204 followers View post →
Zach Yeung MD
@zpyeung · X

RT @drjunaidarsh: Check out our latest addition @ASCO Treatment Guidelines for the treatment of Well Diff. GEP NETS. Thank you to my mentor…

Oct 2, 2023 · 3 shares · 673 followers View post →
Isabella Oronova
@isabellaoronova · X

RT @Globeseek: https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero…

Oct 2, 2023 · 5 shares · 142 followers View post →
Mariam Aboian
@MariamAboian · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 2, 2023 · 7 shares · 4,284 followers View post →
NET Cancer Day
@netcancerday · X

RT @net_connectinfo:

Oct 2, 2023 · 8 shares · 5,531 followers View post →
NET CONNECT
@net_connectinfo · X

Oct 2, 2023 · 27 likes · 8 shares · 1,210 followers View post →
Basel Shoua
@Baselsho · X

RT @drjunaidarsh: Check out our latest addition @ASCO Treatment Guidelines for the treatment of Well Diff. GEP NETS. Thank you to my mentor…

Oct 2, 2023 · 3 shares · 264 followers View post →
Barajas Lab
@LabBarajas · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 1, 2023 · 7 shares · 381 followers View post →
Weill Cornell Medicine Radiology
@WCMRadiology · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 1, 2023 · 7 shares · 2,681 followers View post →
Ali Nabavizadeh
@Ali_Nabavizadeh · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 1, 2023 · 7 shares · 1,999 followers View post →
Scott Tagawa
@DrScottTagawa · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 1, 2023 · 7 shares · 2,795 followers View post →
Joshua D. Palmer, MD
@joshuapalmermd · X

RT @MolecularWCM: Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Met…

Oct 1, 2023 · 7 shares · 1,156 followers View post →
WCM Molecular Imaging and Therapeutics
@MolecularWCM · X

Congratulations to @jana_ivanidze on her contribution to the ASCO Guideline on Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP-NETs, published in @JCO_ASCO!

Oct 1, 2023 · 23 likes · 7 shares · 482 followers View post →
Dr Celestino Gutiérrez González MD
@CelestinoGutirr · X

RT @Globeseek: https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero…

Oct 1, 2023 · 5 shares · 11,288 followers View post →
Junaid Arshad
@drjunaidarsh · X

Check out our latest addition @ASCO Treatment Guidelines for the treatment of Well Diff. GEP NETS. Thank you to my mentors @rachnatshroff @ajscott40 @adasarimd @UAZHemeOnc @UAZCancer Chairs @JaydiDelRivero KimberlyPerez and other wonderful members. https://t.co/TbAZhM8IsF

Oct 1, 2023 · 21 likes · 3 shares · 341 followers View post →
Mark Lewis, MD, FASCO
@marklewismd · X

RT @Globeseek: https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero…

Oct 1, 2023 · 5 shares · 92,918 followers View post →
Thor Halfdanarson
@OncoThor · X

RT @Globeseek: https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero…

Oct 1, 2023 · 5 shares · 5,204 followers View post →
Josh Mailman
@Globeseek · X

https://t.co/1LELevIain nearly impossible to tag all that were involved, honored to have contributed @ASCO @JaydiDelRivero @OncoThor @marklewismd glad that this was released this week as our friends all meet in Montreal for @NANETS1 symposium

Oct 1, 2023 · 17 likes · 5 shares · 1,348 followers View post →
Dr.Lama Amer, MD
@Dr_Lama_Amer · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Oct 1, 2023 · 50 shares · 4,283 followers View post →
Olga Payar
@Olgapaval · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Oct 1, 2023 · 50 shares · 90 followers View post →
Чиж
@rough_fiddle · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Oct 1, 2023 · 50 shares · 9 followers View post →
Sergio Casillas
@scasillasmd · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 104 followers View post →
Top Biomedical Science
@imedverse · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 90,461 followers View post →
Ramón MD
@ramonphysician · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 336 followers View post →
Alejandra Fernández
@AleFer_endo · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 719 followers View post →
ilyas sahin, MD
@ilyassahinMD · X

* https://t.co/cEyujO8cT0

Sep 30, 2023 · 4 likes · 20,812 followers View post →
Vinícius Lorandi
@iamLorandi · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 77 followers View post →
Dr. Estela Rodriguez
@Latinamd · X

https://t.co/SAaxxwwg88

Sep 30, 2023 · 7,852 followers View post →
Midhun Malla
@MallaMidhun · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 356 followers View post →
María San Román Gil
@mariasanroman21 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 239 followers View post →
ROSA GARCIA
@DOCRO74 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 124 followers View post →
Grupo_GGNET
@GgnetGrupo · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 342 followers View post →
NeuroendocrinoSEEN
@NeuroendocrinoS · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 2,883 followers View post →
Ali Alshehri
@prson55 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 258 followers View post →
Angel Azpeitia
@AngelAzpeitia · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 1,473 followers View post →
Dr. Ridwan Ahmed
@realoneahmed · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 850 followers View post →
El Endocrinólogo
@Elendocrinologo · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 119 followers View post →
Joel YR
@YnfaYr · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 116 followers View post →
vnuttk.med
@vnuttk · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 21 followers View post →
Dr.M Khan
@DrManzoorKhan1 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 586 followers View post →
Jaume Capdevila
@Ja_Capdevila · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 2,554 followers View post →
Muslih Urun
@MuslihUrun · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 195 followers View post →
GENEINFO
@LMihajlovi · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 940 followers View post →
Ana Carle
@analeoca66 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 1,328 followers View post →
Anna Malovanna
@malyovannaya_a · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 96 followers View post →
Dr. Birep Aygün
@genperisi · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 13,703 followers View post →
ตชช
@toni_ton_ · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 1,535 followers View post →
Helena Guedes
@GuedesMCH · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 30, 2023 · 50 shares · 116 followers View post →
Fernanda Dias
@fcdias1 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 105 followers View post →
Luisana Molina
@luisanam18 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 430 followers View post →
Alejandro Rosales
@HpbNicaragua · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 1,328 followers View post →
Davide Ciardiello
@DCiardiello · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 471 followers View post →
Rachel Riechelmann
@RachelRiechelm2 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 1,948 followers View post →
Dawood Findakly, MD, FACP
@dawood_findakly · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 1,240 followers View post →
Jorge Aponte Monsalve MD.
@jorapon1 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 309 followers View post →
Dr. Saadvik Raghuram y
@saadvikdr · X

♦️Systemic Therapy for Tumor Control in Metastatic Well-Differentiated GEP Neuroendocrine Tumors: ASCO Guideline update ➡️ SSA for first line ➡️ PRRT for second line ➡️ Chemo for certain cases ⁦@weoncologists⁩ #Medtwitter ⁦@JCO_ASCO⁩ https://t.co/XGc7S9rwYg

Sep 29, 2023 · 3 likes · 704 followers View post →
Jp Solar Vasconcelos
@jaypsv · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 677 followers View post →
Ana K. Valenzuela
@anakvalenzuelav · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 459 followers View post →
Jasmin
@Jas_LohPY · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 38 followers View post →
Emil Lou, MD, PhD, FACP
@cancerassassin1 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 6,946 followers View post →
Jonathan Loree
@jonathanloree · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 817 followers View post →
Kyaw Zin Thein, MD
@kyawzinthein86 · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 828 followers View post →
T.Runciman
@tkatherinerg · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 29 followers View post →
Joao Fogacci
@FogacciJoao · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 724 followers View post →
Diego Soriano
@d_sorianop · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 148 followers View post →
Juan F. Arango Arteaga, MD, MSc.
@JuanArango · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 1,111 followers View post →
Nieves Martinez Lago MD PhD
@DraMartinezLago · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 2,305 followers View post →
Santhosh Ambika
@RenoHemonc · X

RT @dr_yakupergun: Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO…

Sep 29, 2023 · 50 shares · 4,013 followers View post →
Yakup Ergün
@dr_yakupergun · X

Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline

Sep 29, 2023 · 92 likes · 50 shares · 5,837 followers View post →